Abstract
Objective: Residency applications rely on traditional letters of recommendation (tLORs) from faculty or mentors to evaluate applicants. However, interpretation of tLORs can be limited by potential biases, overuse of hyperbolic language, and a lack of longitudinal contact. We aimed to assess whether incorporating peer letters of recommendation (pLORs) would add a complementary perspective to the holistic review of an applicant's attributes and potential. Design: All applicants to a single, university-based general surgery residency program were invited to submit an optional pLOR in the 2023-24 recruitment cycle. Thematic analysis of applicants' pLORs and tLORs was performed to identify patterns and sentiments. Setting: Large general surgery residency program at a single, tertiary academic center. Participants: Applicants selected for an interview for a general surgery residency program who submitted a pLOR in addition to their tLORs (n=95). Results: Ninety-five applicants (78%) selected for interview submitted a pLOR along with their standard application to the categorical (n=77) and preliminary (n=18) tracks. Peer letter writers knew applicants for an average of 6.14 years (SD 4.7). Thematic analysis identified notable differences in pLORs: 1) peer letter writers more often evaluated applicants across diverse settings (professional and personal) over longer time periods, 2) pLORs placed greater emphasis on the applicants' impact on others (peers, individuals, patients), and 3) provided more specific, tangible examples of each positive attribute. Lastly, pLORs summative assessments often included personal language while tLORs tended to stratify applicants using percentiles or coded language. Conclusion: Peer letters of recommendation offer a unique, complementary perspective in the holistic residency application review process. Compared with traditional letters, pLORs provide a richer context of an applicant's impact in a community of their peers, more often providing tangible examples. This perspective is crucial for evaluating applicants as we build diverse and collaborative learning communities each year.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was reviewed and deemed exempt from full review by the Columbia University Institutional Review Board (IRB) under protocol number AAAU9012. In accordance with ethical research guidelines, participant confidentiality was maintained throughout data collection and analysis. No identifiable applicant information was included in the study. This study adheres to the Standards for Reporting Qualitative Research (SRQR) to ensure transparency, rigor, and completeness in reporting.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.